Measuring the economic value of the effects of chemicals on ecological systems and human health
Additional contact information
Anna Alberini: University of Maryland
No 116, OECD Environment Working Papers from OECD Publishing
This paper reviews and discusses the existing methods for placing a value on the effects of chemicals on human health and the environment. It surveys both methods and non-market methods, discussing their advantage and limitations. For example, when valuing non-fatal illnesses, the cost-of-illness approaches captures labour income lost to illness and medical expenditures undertaken to mitigate the illness, but fails to account for the value of the disutility of the illnesses. The paper also discusses mortality risk valuation, and the widely used metric termed the Value of a Statistical Life, the difficulties associated with estimating it, and the appropriateness of any adjustments for futurity, age, and the nature of the risk itself. Finally, the paper takes up the issue whether the source of the health risks (e.g., chemicals versus other forms of pollution versus others) affects how much the public values reducing those risks.
Keywords: economic valuation; monetised benefits; non-market valuation; regulation of chemicals; toxics (search for similar items in EconPapers)
JEL-codes: D61 J17 K32 Q51 Q53 Q57 Q58 (search for similar items in EconPapers)
New Economics Papers: this item is included in nep-agr, nep-env and nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:oec:envaaa:116-en
Access Statistics for this paper
More papers in OECD Environment Working Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().